USX:CERE - Cerevel Therapeutics Holdings Inc

Cerevel Therapeutics Holdings
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance (Live Price)

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts
• Options

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	21.55% -1.9%	19% -11.9%	18.69% -1.6%	18.6% -0.5%	18.57% -0.2%	17.7% -4.7%	17.63% -0.4%	17.56% -0.4%	17.56% 0%	17.51% -0.3%	15.2% -13.2%
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0 -	0 -	0 -	0 -	0 -	0 -	0 -	0 -	0 -	0 -	0 -
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	391M -4.2%	733.48M 87.6%	688.92M -6.1%	618.55M -10.2%	596.66M -3.5%	1.09B 83.3%	1.02B -6.9%	930.35M -8.6%	894.35M -3.9%	821.96M -8.1%	1.24B 51.3%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	97.12M 42.7%	104.4M 7.5%	110.19M 5.5%	97.05M -11.9%	143.84M 48.2%	490.35M 240.9%	496.58M 1.3%	498.64M 0.4%	543.85M 9.1%	549M 0.9%	569.55M 3.7%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	293.89M -13.6%	629.08M 114.1%	578.73M -8.0%	521.5M -9.9%	452.81M -13.2%	603.36M 33.2%	521.24M -13.6%	431.71M -17.2%	350.5M -18.8%	272.96M -22.1%	673.75M 146.8%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-143.81M -	-167.5M -	-178.55M -	-209.78M -	-221.82M -	-258.45M -	-293.19M -	-320.46M -	-340.13M -	-332.36M -	-342.3M -
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	22.1M -57.2%	17.01M -23.0%	387.82M 2180.2%	347.49M -10.4%	331.26M -4.7%	673.88M 103.4%	197.22M -70.7%	93.63M -52.5%	140.09M 49.6%	250.47M 78.8%	138.39M -44.7%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	331.26M -4.7%	673.88M 103.4%	197.22M -70.7%	93.63M -52.5%	140.09M 49.6%	250.47M 78.8%	138.39M -44.7%	155.68M 12.5%	177.72M 14.2%	157.68M -11.3%	418.43M 165.4%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-166.9M -	-184.49M -	-178.55M -	-217.82M -	-224.08M -	-263.02M -	-293.19M -	-322.22M -	-340.76M -	-332.81M -	-346.11M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-176.44M -	-199.46M -	-59.05M -	-242.65M -	-90.47M -	-317.76M -	-92.81M -	-104.29M -	-99.53M -	-96.36M -	-432.84M -
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-176.44M -	-199.46M -	-225.33M -	-242.65M -	-279.88M -	-317.76M -	-351.51M -	-387.5M -	-396.57M -	-392.99M -	-432.84M -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-1.383 -	-1.356 -	-1.65 -	-1.71 -	-1.9 -	-2.13 -	-2.32 -	-2.53 -	-2.55 -	-2.5 -	-2.67 -
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-60.04% -	-51.69% -	-46.79% -	-56.33% -	-74.96% -	-51.57% -	-63.91% -	-81.31% -	-98.73% -	-89.69% -	-72.44% -
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-45.12% -	-45.13% -	-39.73% -	-47.27% -	-56.68% -	-34.78% -	-41.19% -	-50.04% -	-53.19% -	-41.03% -	-38.29% -